Publications by authors named "Nicholson B Perkins"

Claim this Profile
C
Correction: Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia Infections.
Mohammed Al Musawa, Ashlan J Kunz Coyne, Sara Alosaimy, Kristen Lucas, Melanie Rae Schrack, Nicholson B Perkins

Infect Dis Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eravacycline use in immunocompromised patients: multicenter evaluation of timely versus late initiation on clinical outcomes.
Ashlan J Kunz Coyne, Sara Alosaimy, Kristen Lucas, Taylor Morrisette, Kyle C Molina, Nicholson B Perkins

Microbiol Spectr· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes of Eravacycline in Patients Treated for Stenotrophomonas maltophilia Infections.
Mohammed Al Musawa, Ashlan J Kunz Coyne, Sara Alosaimy, Kristen Lucas, Melanie Rae Schrack, Nicholson B Perkins

Infect Dis Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WNT5B drives osteosarcoma stemness, chemoresistance and metastasis.
Rachel S Perkins, Glenn Murray, Sarocha Suthon, Lindsey Davis, Nicholson B Perkins

Clin Transl Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eravacycline, the first four years: health outcomes and tolerability data for 19 hospitals in 5 U.S. regions from 2018 to 2022.
Ashlan J Kunz Coyne, Sara Alosaimy, Kristen Lucas, Abdalhamid M Lagnf, Taylor Morrisette, Nicholson B Perkins

Microbiol Spectr· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to defervescence evaluation for extended- vs. standard-infusion cefepime in patients with acute leukemia and febrile neutropenia.
Robert Crawford, Nicholson B Perkins, Diana A Hobbs, Athena L V Hobbs

Pharmacotherapy· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii.
Sara Alosaimy, Taylor Morrisette, Abdalhamid M Lagnf, Leonor M Rojas, Madeline A King, Nicholson B Perkins

Microbiol Spectr· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis